SULFONYL CONTAINING COMPOUNDS AS CYSTEINE PROTEASE INHIBITORS
The present invention is directed to compounds that are inhibitors of cysteine proteases, in particular, cathepsins B, K, L, F, and S and are therefore useful in treating diseases mediated by these proteases. The present invention is directed to pharmaceutical compositions comprising these compounds...
Gespeichert in:
| 1. Verfasser: | |
|---|---|
| Format: | Patent |
| Sprache: | eng ; fre |
| Schlagworte: | |
| Online-Zugang: | Volltext bestellen |
| Tags: |
Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
|
| Zusammenfassung: | The present invention is directed to compounds that are inhibitors of cysteine proteases, in particular, cathepsins B, K, L, F, and S and are therefore useful in treating diseases mediated by these proteases. The present invention is directed to pharmaceutical compositions comprising these compounds and processes for preparing them.
Composés qui sont des inhibiteurs des cystéine protéases, en particulier des cathepsines B, K, L, F et S, et qui sont par conséquent utiles pour traiter des maladies médiées par ces protéases. La présente invention concerne également des compositions pharmaceutiques contenant ces composés et des procédés de préparation desdites compositions. |
|---|